NCT02558283 - A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults | Biotech Hunter

Enrollment

175

Participants

Timeline

Start Date

January 25, 2016

Primary Completion Date

June 19, 2017

Study Completion Date

June 19, 2017

Conditions

Nasolabial Fold

Interventions

DEVICE

JUVÉDERM® VOLIFT® with Lidocaine

JUVÉDERM® VOLIFT® with lidocaine injected into the nasolabial fold on Day 1, with optional touch-up injections into the nasolabial fold on Month 1.

DEVICE

Restylane®

Restylane® injected into the nasolabial fold on Day 1, with optional touch-up injections into the nasolabial fold on Month 1.

Trial Locations (5)

China Japan Friendship Hospital, Beijing

Peking University Third Hospital, Beijing

General Hospital of Guangzhou Military Command of PLA, Guangzhou

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Guangzhou

Shanghai 9th Hospital, Shanghai